Phosducin (PDC)

Phosducin is a small, cytosolic regulatory phosphoprotein highly expressed in photoreceptor cells of the retina and certain regions of the nervous system[2][4]. It is characterized by a phosducin-like domain and consists of two major domains: an N-terminal domain (main site of interaction with G-protein βγ subunits) and a C-terminal thioredoxin-like domain[4][6]. Phosducin regulates heterotrimeric G-protein signaling by binding to G-protein beta-gamma (Gβγ) dimers, modulating their availability to interact with G-protein alpha (Gα) subunits and downstream effectors, and thus influencing visual signal transduction and resensitization of photoreceptors to light[1][2][4]. Binding of phosducin to Gβγ is dynamically regulated through phosphorylation (notably at serine residues 54 and 73), which alters its interaction with both Gβγ and 14-3-3 proteins[4]. Unlike other members of the phosducin family, such as phosducin-like proteins (PhLPs), canonical phosducin does not generalize as a major chaperone for cellular protein folding, but plays a specialized role in the retina in response to light adaptation[1]. There is currently no strong evidence that phosducin is a direct target of known therapeutic drugs, nor is it a routine clinical biomarker or associated with major safety or toxicity concerns as a drug target[1][2][4].

Other names

PhosducinPDCPHDMEKA33 kDa phototransducing proteinProtein MEKAPhLOPPhLPG beta gamma binding proteinphosducin-like orphan protein